Transaction · 0002043395-26-000012

Sayad Pierre Sargis

Sayad Pierre Sargis, CMO, reported an open-market or private sale at FENNEC PHARMACEUTICALS INC. involving 12000.000000 shares for an estimated $146160.00. Reported holdings after the transaction were 9519.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCMO
FENCFENNEC PHARMACEUTICALS INC.
Filing timeSep 01
Trade dateAug 31, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$12.35
Pre-filing
1mo ago -22.5%1w ago -7.7%1d ago -5.9%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

FENC price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
FENC since 2026-09-01Filed 2 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0002043395-26-000012
Common Shares
Transaction date
Aug 31, 2026
Filed Sep 01, 2026, 12:15 AM · 1d delay
Shares
12.0k sh
$1.21k per share
Estimated value
-$14.6M
Computed from shares × price
Holdings after
9.51k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Large Holdings Reduction
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents shares released from restriction from shares awarded 3/28/2025.

  2. F2

    Represents sale of previously vested restricted shares and vested performance shares.

Original filing · 0002043395-26-000012
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

FENC